DCM Advisors’s NuVasive, Inc. NUVA Stock Holding History

DCM Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,000	Closed	-$344K	–	226
2022 Q2	$344K	Buy	+7,000	New	+$375K	0.15%	137

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

DCM Advisors's NUVA Position: Q3 2022 in Review

DCM Advisors sold out of NuVasive, Inc. (NUVA) in Q3 2022, closing a stake of 7,000 shares — an estimated $344K sold.

DCM Advisors first reported a position in NUVA in Q2 2022 and held it in 1 quarter. The position peaked at $344K in Q2 2022. 232 funds tracked by Wall St. Rank hold NUVA as of Q3 2022.

DCM Advisors reported no remaining NuVasive, Inc. position as of Q3 2022 after selling out during the quarter.
DCM Advisors sold 7,000 NuVasive, Inc. shares in Q3 2022, an estimated $344K.
DCM Advisors first reported a position in NuVasive, Inc. in Q2 2022 and held it in 1 quarter.
DCM Advisors's NuVasive, Inc. position peaked at $344K in Q2 2022.
232 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2022.

Based on DCM Advisors's 13F filing for Q3 2022, filed 11 Sep 2023.